• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与单腔除颤器相比,双腔植入式心脏复律除颤器可减少与心房颤动相关的临床不良事件:DATAS试验的亚分析

Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.

作者信息

Ricci Renato Pietro, Quesada Aurelio, Almendral Jesus, Arribas Fernando, Wolpert Christian, Adragao Pedro, Zoni-Berisso Massimo, Navarro Xavier, DeSanto Tiziana, Grammatico Andrea, Santini Massimo

机构信息

Heart Diseases Department, San Filippo Neri Hospital, Via Martinotti 20, 00135 Rome, Italy.

出版信息

Europace. 2009 May;11(5):587-93. doi: 10.1093/europace/eup072.

DOI:10.1093/europace/eup072
PMID:19401341
Abstract

AIMS

The aim of the present analysis of the DATAS study was to compare the impact of dual- vs. single-chamber defibrillators on atrial fibrillation (AF) occurrence and AF-related clinical events in patients with Class I indication for implantable cardioverter defibrillators (ICDs) and no indication for dual-chamber pacing.

METHODS AND RESULTS

Three hundred and thirty-four patients were randomized, through a centralized assignment, to single-chamber ICDs, dual-chamber ICDs programmed as single-chamber ICDs, and dual ICDs with full diagnostics and AF prevention and therapy capabilities. The latter two groups in the first 8 months of the study, when the study design was that of a randomized parallel trial, were compared in the present analysis. The primary endpoint was composed by the following AF-related clinical events: permanent AF, AF-related hospitalizations, cardiac-embolic events, and inappropriate ICD shocks due to AF misclassification. Two hundred and twenty-three patients were available for this analysis, of whom 111 in the single-chamber-simulated group and 112 in the dual-chamber true group. Atrial fibrillation-related composite endpoint raw incidence was 9 of 111 (8.1%) in the single-chamber group vs. 1 of 112 (0.9%) in the dual-chamber group (P = 0.0098 by Fisher's exact test). Single-chamber ICDs were associated with a significantly higher risk to develop the AF-related composite endpoint by Cox regression analysis (hazard ratio 8.25, 95% CI 1.03-65.96, P = 0.047) and by the Kaplan-Meier survival analysis (log-rank test, P = 0.047).

CONCLUSION

Dual-chamber ICDs compared with single-chamber ICDs reduced the incidence of an endpoint composed by permanent AF, AF-related hospitalizations, and ICD shocks deemed inappropriate due to AF misclassification.

摘要

目的

本项对DATAS研究的分析旨在比较双腔与单腔除颤器对有植入式心脏复律除颤器(ICD)I类适应症且无双腔起搏适应症患者房颤(AF)发生情况及AF相关临床事件的影响。

方法与结果

334例患者通过集中分配随机分为单腔ICD组、程控为单腔ICD的双腔ICD组以及具有完整诊断及AF预防和治疗功能的双腔ICD组。在本分析中,比较了研究设计为随机平行试验时前两组在前8个月的情况。主要终点由以下AF相关临床事件组成:永久性AF、AF相关住院、心脏栓塞事件以及因AF误分类导致的不适当ICD电击。223例患者可用于此次分析,其中单腔模拟组111例,双腔真实组112例。单腔组AF相关复合终点原始发生率为111例中的9例(8.1%),双腔组为112例中的1例(0.9%)(Fisher精确检验P = 0.0098)。通过Cox回归分析(风险比8.25,95%CI 1.03 - 65.96,P = 0.047)和Kaplan - Meier生存分析(对数秩检验,P = 0.047),单腔ICD与发生AF相关复合终点的风险显著更高相关。

结论

与单腔ICD相比,双腔ICD降低了由永久性AF、AF相关住院以及因AF误分类导致的不适当ICD电击组成的终点发生率。

相似文献

1
Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.与单腔除颤器相比,双腔植入式心脏复律除颤器可减少与心房颤动相关的临床不良事件:DATAS试验的亚分析
Europace. 2009 May;11(5):587-93. doi: 10.1093/europace/eup072.
2
Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.与单腔设备相比,双腔除颤器可减少具有临床意义的不良事件:DATAS(双腔与房性快速心律失常不良事件研究)试验结果
Europace. 2008 May;10(5):528-35. doi: 10.1093/europace/eun072. Epub 2008 Apr 7.
3
The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator.DATAS的原理与设计:一项评估双腔(DDED)除颤器临床益处的对照随机试验。
Europace. 2004 Mar;6(2):142-50. doi: 10.1016/j.eupc.2003.11.011.
4
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.双腔与VVI植入式心脏除颤器(DAVID)试验:原理、设计、结果、临床意义及对未来试验的启示
Card Electrophysiol Rev. 2003 Dec;7(4):468-72. doi: 10.1023/B:CEPR.0000023165.20987.b1.
5
Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.与单腔治疗相比,双腔治疗可降低植入式心律转复除颤器不适当电击的风险:随机 OPTION 研究结果。
JACC Heart Fail. 2014 Dec;2(6):611-9. doi: 10.1016/j.jchf.2014.05.015. Epub 2014 Oct 1.
6
Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy.他汀类药物治疗与心房颤动或心房扑动减少及不适当电击治疗之间的关联。
Europace. 2008 Jul;10(7):854-9. doi: 10.1093/europace/eun128. Epub 2008 May 20.
7
Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.在具有心房治疗功能的双腔植入式心脏复律除颤器(ICD)患者中,通过治疗心房颤动减少室性快速心律失常:REVERT-AF研究
Europace. 2007 Jul;9(7):534-9. doi: 10.1093/europace/eum035. Epub 2007 Apr 17.
8
Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.用于植入式除颤器心律诊断的双腔与单腔检测增强:检测室上性心动过速研究
Circulation. 2006 Jun 27;113(25):2871-9. doi: 10.1161/CIRCULATIONAHA.105.594531. Epub 2006 Jun 12.
9
Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.心房颤动可预测一级预防植入式心脏复律除颤器患者的恰当电击。
Europace. 2006 Aug;8(8):566-72. doi: 10.1093/europace/eul081.
10
Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.植入时及随访1年时双腔心脏复律除颤器的适应证:单腔除颤器时代的回顾性分析
Europace. 2001 Apr;3(2):132-5. doi: 10.1053/eupc.2001.0157.

引用本文的文献

1
Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.单导联植入式心脏复律除颤器系统中使用浮动心房感知偶极检测亚临床房颤:SENSE试验结果
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1994-2001. doi: 10.1111/jce.14081. Epub 2019 Aug 5.
2
Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients.未来研究重点:老年患者的植入式心脏复律除颤器治疗
J Gen Intern Med. 2015 Dec;30(12):1812-20. doi: 10.1007/s11606-015-3411-6.
3
Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.
双腔植入式心脏复律除颤器使用情况的差异:来自国家心血管数据注册库的结果
Arch Intern Med. 2012 Apr 23;172(8):634-41; discussion 641. doi: 10.1001/archinternmed.2012.394.
4
Atrial fibrillation in cardiac channelopathies.心脏离子通道病中的心房颤动。
Indian Pacing Electrophysiol J. 2009 Nov 1;9(6):342-50.
5
Recurrent syncope associated with a distinct ECG pattern consisting of short QT interval, early repolarization and atrioventricular block.复发性晕厥,伴有由短QT间期、早期复极和房室传导阻滞组成的独特心电图模式。
Clin Res Cardiol. 2009 Dec;98(12):807-10. doi: 10.1007/s00392-009-0083-4. Epub 2009 Sep 23.